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Abstract
Alzheimer’s disease (AD) patients are often subject to vascular dysfunction besides their specific CNS pathology, which warrants further
examination of the interaction between vascular factors and the development of dementia. The association of decreased cerebral blood flow
(CBF) or hypertension with AD has been a target of growing interest. Parallel with physiological changes, the cerebral capillaries in AD
are also prone to degenerative processes. The microvascular abnormalities that are the result of such degeneration may be the morphological
correlates of the vascular pathophysiology pointing to a compromised nutrient transport through the capillaries. Animal models have been
developed to study the consequences of hypertension and reduced CBF. Spontaneously hypertensive rats are widely used in hypertension
research whereas ligation of the carotid arteries has become a method to produce cerebral hypoperfusion. Based on these models, we propose
a relationship between hypertension, cerebral hypoperfusion, cerebral capillary malformation and cognitive decline as it occurs in AD. We
suggest that the above conditions are functionally related and can contribute to the progression of AD. © 2000 Elsevier Science Inc. All
rights reserved.
Keywords: Alzheimer’s disease; Chronic hypertension; Cerebral hypoperfusion; Carotid occlusion; Cerebral capillaries
1. Hypertension in Alzheimer’s disease
Vascular factors, which may contribute to the develop-
ment of dementia, have gained growing attention in recent
years [10,55]. Particularly hypertension, being a frequently
occurring condition with advancing age has come into focus
for its major role in the development of stroke and its
association with atherosclerosis. Clinical studies were
aimed at clarifying a presumed relationship between chronic
hypertension and the onset of dementia because an elevated
blood pressure was thought to interfere with proper cerebral
circulation and neuronal metabolism. This idea found com-
pelling support in the observation that vascular dementia
(VD) consistently coincided with high blood pressure [18,
23,26,33]. The role of hypertension in the pathogenesis of
Alzheimer’s disease (AD), another prominent type of de-
mentia appeared to be more complicated to elucidate. Sev-
eral epidemiological studies investigated the interaction of
elevated blood pressure and AD but a final agreement about
a causal relationship has not been reached, yet. Neverthe-
less, based on several studies [32,14,48] a hypothesis was
proposed that the blood pressure of AD patients probably
varies according to the stage of the disease and that hyper-
tension characteristically precedes the diagnosis of cogni-
tive impairment with at least 10 years [49]. According to
this theory, patients suffering from chronic hypertension
during their midlife have a higher chance for developing
AD at older age. The theory proposed by Skoog [49] was
further underscored by the detection of an increased amount
of senile plaques and neurofibrillary tangles in the brains of
hypertensive individuals [50]. Thus, chronically high blood
pressure can be considered as a condition, which increases
the potential to develop dementia. Such tendency was also
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indirectly shown by the preventive effect of anti-hyperten-
sive drugs on the incidence of AD [19].
In line with the hypothesis that hypertension can act as a
risk factor for AD, in vitro and in vivo experiments were
designed to investigate the effect of circulating b-amyloid -
the peptide typically accumulating in AD brains—on blood
pressure. Isolated aorta preparations and in vivo b-amyloid
infusion demonstrated the vasoconstrictive effect of b-amy-
loid [1,52].
2. Hypertension, dementia, and CBF
Patients suffering from chronic hypertension can often
display signs of additional vascular abnormalities. For ex-
ample, high blood pressure is generally accompanied by
arteriosclerosis or deformations of larger peripheral vessels
exerting additional harmful effects on the circulation. The
rigid vessel walls and the considerably narrowed lumen
diameter further hinder the maintenance of a normal blood
pressure by increasing peripheral resistance. Besides such
systemic damage, abnormally high pressure can also
threaten an optimal cerebral blood supply, as it was show in
hypertensive individuals. When the CBF of hypertensive
patients was measured with PET or the 1333e-inhalation
method, and the data compared to those of normotensive
individuals, reduced flow rate was recorded in the hyper-
tensive patients [21,37,39]. In addition, the drop in CBF was
less pronounced in high blood pressure patients who were
receiving an anti-hypertensive treatment [39].
Animal studies lead to similar observations: the CBF of
spontaneously hypertensive (SHR) rats appeared to be re-
duced, as well, where the compromised cerebral circulation
was already detectable at 4 months of age [22,31]. This
latter finding suggests that an accelerating age effect in a
hypertension-induced drop in CBF is not crucial; instead,
hypertension itself can already create an unfavorable cere-
bral circulation. Nevertheless, the enhanced breakdown of
cerebral circulation at older age should not be neglected
considering that even lower CBF values were measured in
aged hypertensive animals [31]. Further indication of a
decreased CBF can be an elevated lactate concentration in
the jugular venous blood, which indicates cerebral anaero-
bic glycolisis. An increased jugular lactate concentration
was also described in hypoperfused SHR rats [12]. A con-
ceivable explanation of reduced CBF in hypertension may
be that a typical atherosclerosis of the carotid arteries con-
tributes to the development of insufficient cerebral blood
supply. Another interpretation may argue for a damaged
cerebrovascular autoregulation. Dickinson [12] however
discussed a preserved cerebrovascular autoregulatory ca-
pacity of the brain and suggested an alternative deficient
vascular process. According to this view, the cyclic opening
and shutting of cerebral capillaries normally cares for a
regular oscillation in the cerebral arteriolar calibre, which
process seems to be compromised in the SHR animals.
Whatever the underlying mechanism may be, a reduced
CBF seems to consistently accompany chronic hyperten-
sion.
A defective brain circulation has also become a target of
increasing interest in the pathophysiology of AD. Clinical
measurements of regional CBF by the noninvasive SPECT
method have indicated that AD is accompanied by a de-
creased regional CBF in the hippocampal formation, the
temporal cortex, the parietal cortex and the frontal cortex
[4,11,13,29,36,40,41,46,53]. The region specificity is re-
markable because the typical neuropathological hallmarks
of AD also appear first and most extensively in the entorhi-
nal region and the temporal cortex. Based on these obser-
vations, it would still remain uncertain whether a reduced
CBF in AD is caused by a possible loss of cerebrovascular
autoregulation due to the disease-specific decaying of neu-
ronal integrity or whether the low CBF is a contributing
factor to the development of dementia symptoms. The latter
possibility appears to be more probable considering the
neurological complications arising shortly after a cardiac
surgery. Case reports and reviews about the neural effects of
such a serious surgical intervention reported that the brain
can suffer hypoperfusion during the surgical procedure after
which recovering patients often have postoperative cogni-
tive disorders [24,25,51]. A plausible explanation of the
phenomenon is that the decreased, intraoperative cerebral
perfusion can create an imbalance between oxygen demand
and supply in the brain, which is probably responsible for
the postoperative memory deficit after cardiac surgery [5].
Further evidence supporting the view that reduced CBF
can precede neuronal degeneration in dementia, would be an
increased oxygen extraction accompanying the decreased
CBF in AD. Pantoni and Garcia [43] noted that lowered
CBF was considered secondary to dementia-related cerebral
atrophy in case an increase in oxygen extraction would not
couple the drop in CBF. However, recent reports suggested
that oxygen extraction in AD brains increased whereas CBF
reduced [36,53]. These findings support the hypothesis that
compromised cerebral perfusion arises before neuronal dis-
integration in dementia.
In summary, a reduced CBF has been reported concur-
rent with chronic hypertension both in humans and in ex-
perimental animals. Furthermore, the involvement of a de-
creased CBF in AD has also been shown. Such similarity in
the alteration of cerebral circulation in the two pathological
conditions, namely chronic hypertension and AD, may im-
ply an analogous chain of cerebrovascular and neural events
in the two conditions. Below, we intend to offer an expla-
nation of such a possible sequence of cerebral processes
triggered by an insufficient brain perfusion.
3. Reduced CBF and cerebral capillary ultrastructure
Separate studies have investigated cerebrovascular phys-
iological parameters and their structural correlates in patient
236 E. Farkas et al. / Neurobiology of Aging 21 (2000) 235–243
groups of AD. The clinical line of research presented mea-
surements of CBF with non-invasive scanning methods
whereas pathology-oriented research groups analyzed vas-
cular integrity and described morphological alterations of
cerebral vessels in AD.
Sufficient blood supply to the brain can be of critical
importance in taking care of a proper nutrient delivery and
meeting the metabolic demands of an optimal cognitive
performance. A decreased CBF can impose a chronically
reduced availability of glucose and oxygen to the brain
leading to suboptimal neuronal metabolism. Such energy
crisis is reflected in the findings that the cerebral metabolic
rate for oxygen and glucose, as well as the density of
glucose transporter sites in the cerebral capillary walls were
distinctly reduced in AD [20,27,28,30,35]. The deprivation
of neural tissue of the essential nutrients can derive from
either the lower flow rate itself - implying a reduced volume
of blood reaching the cerebral vasculature—or the affected
permeability of the capillary walls due to structural anom-
alies [8]. Most probably, the two factors are mutually and
progressively related, and a chronically low CBF together
with the abnormal vascular morphology can jeopardize suf-
ficient nutrient trafficking in the brain.
The cerebrovascular structural lesions that can appear in
AD were shown by a number of research groups. Buee´ et al.
[2] described abnormally twisted, tortuous fragmented ves-
sels or glomerular vascular loop formations in a light mi-
croscopic study whereas Claudio [3] reported ultrastructural
capillary pathology in biopsy tissue from AD brains at the
electron microscopic level. Others reported similar capillary
deformities found in post mortem AD material [30,47]. Our
own studies also gathered evidence that the cerebrocortical
capillaries of AD and other dementing patients suffer con-
siderable pathological changes [15,16]. Electron micro-
scopic analysis of post mortem samples from the cingulate
cortex demonstrated that the capillary basement membrane
was a preferential site of ultrastructural degradation in AD
and Parkinson’s disease with dementia (PDd). The local
thickening and distortion of the basement membrane, and
extracellular deposits in the vessel walls (that often con-
tained collagen) appeared to be a prominent degenerative
feature whereas the condition of pericytes was not affected.
The local thickening of the basement membrane means
unusually enlarged basement membrane segments where
the thickness of the membrane is at least twice of the intact
parts of the same vessel. Additional collagen fiber deposits
can be also frequently encountered in the capillary basement
membrane of affected microvessels. Such capillaries with
basement membrane deposits occurred two times more fre-
quently in AD and PDd brains than in control cases in our
study (Fig. 1A) indicating a dementia-related damage. This
interpretation was supported by a correlation analysis be-
tween capillary degeneration and age of the patients in our
study, where no significant correspondence was found [16].
The decreased CBF and a compromised cerebral capil-
lary ultrastructure in AD curiously coincide but their pro-
posed functional and causal interaction remains to be dem-
onstrated. Animal models offer a good possibility to reveal
the potential underlying mechanisms that link reduced CBF
and the decaying capillary condition in the brain. For ex-
ample, the permanent ligation of both common carotid ar-
teries of rats (two vessel occlusion, 2VO) was developed as
a model of chronic cerebral hypoperfusion, where the blood
supply to the brain is reduced to about 70% of the original
Fig. 1. The proportion of cerebral capillaries with capillary wall deposits in the human cingulate cortex (A), the rat hippocampus CA1 region in chronic
experimental cerebral hypoperfusion (2VO)(B) and the rat frontal cortex in chronic hypertension (C). *p ,0.05, **p ,0.01, analyzed by the non-parametric
Mann–Whitney–U-test. Abbreviations: A) AD: Alzheimer’s disease; C: human control cases; PDd: Parkinson’s disease with AD-like neuropathology. B)
2VO: experimental cerebral hypoperfusion imposed by permanent bilateral carotid occlusion in Wistar rats; SHAM: sham operated control group. C)
SHR-SP: spontaneously hypertensive stroke prone rat strain; WKY: normotensive control group.
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rate [54]. This agrees with the drop in CBF in the hippocam-
pus and temporal cortex of AD patients [13,41]. We have
shown recently that 2VO causes structural abnormalities of
cerebral capillaries reminiscent of those seen in AD. Such
microvascular lesions in the rat include region-specific local
thickening of the basement membrane and microvascular
collagen accumulation in the hippocampal formation after
14 months of cerebral hypoperfusion [6]. Our results
showed that the incidence of capillaries with basement
membrane pathology in the hippocampal CA1 region in-
creased from a 30% control value found in sham operated
animals to more than 50% in the 2VO group (Fig. 1B).
Thus, the experiment suggests a functional link between
chronically reduced CBF and cerebral capillary damage,
with cerebral hypoperfusion being the likely trigger for the
formation of the ultrastructural vascular deformities.
It is interesting to note that we have also encountered
microvascular lesions in the frontal cortex of spontaneously
hypertensive stroke prone rats (SHR-SP) [17] (Fig. 2.). Like
in the 2VO model, the ratio of affected vessels increased
from 30% of normotensive controls to 50% in the SHR-SP
strain at the age of 60 weeks (Fig. 1B). Besides, others had
shown that the hypertensive animals had a reduced CBF
[22,31]. These findings provide additional evidence for
causal interaction between chronically low CBF and micro-
vascular degeneration, in this case, under hypertensive con-
ditions.
4. Cerebral capillary ultrastructure and cognitive
impairment
The AD patients in our study showing the above de-
scribed typical capillary aberrations had been diagnosed as
probable or definite cases with respect to the CERAD scale
and they were in phase IV or V of the disease according to
Fig. 2. Electron microscopic computer generated images of ultrastructural cerebral capillary lesions in experimental cerebral hypoperfusion (2VO) (A, B, C)
and chronic hypertension in spontaneously hypertensive stroke prone rats (SHR-SP) (D, E, F). A and D: local thickening of the basement membrane in 2VO
(A) and SHR-SP (D). B and E: amorphous, fibrous deposits in the basement membrane in 2VO (B) and SHR-SP (E). C and F: fibrosis in the capillary
basement membrane in 2VO (C) and SHR-SP (F). Abbreviations: *: capillary basement membrane, e: endothelial cell, l: microvascular lumen, p: pericytic
cytoplasm.
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the Braak scoring system (Table 1) [16]. The dementing
Parkinson’s disease cases were displaying similar neuropa-
thology (Table 1). Such neuropathological classification im-
plicates serious cognitive impairment, which coincided with
the typical vascular pathology (local thickening of the mi-
crovessel walls) that we observed. The exact contribution of
capillary basement membrane degeneration in the develop-
ment of cognitive dysfunction in AD is hard to specify
based on post mortem analysis alone but the 2VO experi-
ments may offer some guidelines. 2VO animals were re-
peatedly tested in spatial learning paradigms such as the
Morris water maze and the eight arm radial maze to estab-
lish their learning and memory capacity. Carotid occlusion
was performed either on young or on old animals [6,7,38,
42] and behavioral testing after permanent vessel occlusion
was performed at various time points depending on the
experimental paradigm. The post-operative period between
surgery and testing varied in different studies from 2 weeks
Fig. 3. Learning capacity of Wistar rats after 14 months of chronic experimental cerebral hypoperfusion (2VO) as shown by the Morris water maze. A: the
median distance rats traveled before reaching the escape platform in the water maze. *p,0.05. B: correlation between cognitive performance measured on
Day 2 of the training session in the water maze (see graph A) and the percentage of capillaries with basement membrane deposits in the hippocampus CA1
area. E: sham operated animals, F: 2VO rats.
Table 1
Clinical and pathological characterisation of the individual patients
Casus Age (years) Gender Clinical diagnosis Lewy body score CERAD Braak stage
20.820 67 m Septichaemia
20.841 66 m Myocardiac
infarct
20.848 64 m Myocardiac
infarct
96.37 63 m Myocardiac
infarct
97.454 78 f Lung cancer
20.804 77 m Alzheimer’s — definite V
20.815 78 f Alzheimer’s — definite V
20.883 87 f Alzheimer’s — probable IV
21.055 83 m Alzheimer’s — probable IV
96.83 85 m Alzheimer’s — definite V
20.637 66 m Parkinson’s N probable III
20.678 70 f Parkinson’s N definite IV
20.884 80 f Parkinson’s N probable III
21.077 86 f Parkinson’s L probable III–IV
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[42,44] to 14 months [6]. Despite all these variables, the
experimental cerebral hypoperfusion consistently lead to a
subtle but significant learning impairment in all these cases.
In addition, the poorer spatial memory of the 2VO rats was
reflected in a deteriorating neuronal integrity. After 180
days of permanent 2VO, apoptotic neuronal cell death and
an increased glial GFAP expression took place in the hip-
pocampal CA1 region [44,45].
Our own 2VO studies focused more specifically on the
alteration of capillary integrity in the hippocampal region.
The capillary basement membrane displayed local thicken-
ing and collagen deposits considerably more frequently in
the 2VO animals than in sham operated controls as an
apparent result of chronic cerebral hypoperfusion. We fur-
thermore established a correlation between the percentage
of capillaries with ultrastructural pathology in the hip-
pocampus and the water maze performance of the animals at
14 months after the induction of 2VO (Fig. 3). The distance
the animals traveled to find the hidden platform in the maze
was taken as a marker of their learning capacity. We found
a highly significant correlation in the hippocampal CA1
region between deteriorating cerebral microvascular condi-
tion and declining spatial learning skills indicated by the
increased length of the animals’ swim paths [6]. Thus, the
2VO-induced chronic cerebral hypoperfusion showed an
overt tendency to hamper spatial learning, which paralleled
capillary damage in the hippocampus.
Independent of the 2VO experiments, SHR-SP animals
were also tested in the Morris water maze and radial arm
maze for their learning skills [6,7,38,42,44,56]. The Morris
water maze test detects hippocampus-dependent spatial
learning skills and reference memory whereas the radial arm
maze is designed to test both reference and short-term
working memory. Comparison of the performance of nor-
motensive and hypertensive (SHR-SP) animals in these ex-
perimental paradigms clearly demonstrated the effect of
hypertension on brain function. The learning tests of
SHR-SP rats lead to results, which corresponded with the
findings in the cerebral hypoperfusion experiments (2VO).
Both the 2VO animals and the SHR-SP rats performed
significantly worse than their controls in the Morris water
maze or the eight arm radial maze. The 2VO animals and
the SHR-SP rats swam a longer distance than their controls
before locating the hidden platform in the water maze and
committed more errors in the radial maze by entering arms
that they had already visited. Such observations are con-
Fig. 4. Rearing (A) and grooming (C) activity of hypertensive SHR-SP rats (F) compared to normotensive WKY (o) in the novelty induced behavioral arousal
test (small open field). The x-axis shows the observation time. Behavioral scores were calculated for every 10 min of the 60-min observation period. B:
Rearing scores of the entire 60-min observation time. *p,0.05. D: Grooming scores of the entire 60-min observation time. *p,0.05.
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vincing evidence for a suboptimal learning and memory
capacity in chronic hypertension.
Moreover, our experiments showed that 40-week old
SHR-SP rats performed significantly worse than their Wistar–
Kyoto controls in the hippocampus-dependent holeboard spa-
tial learning test [34]. The compromised learning capacity of
the hypertensive group was also consistently reflected in learn-
ing task-elicited neuronal biochemical parameters in the hip-
pocampal CA1 area. Specifically, PKCg immunoreactivity,
which is normally enhanced by the learning process and is a
sign of neuronal activation, was found less pronounced in
SHR-SP animals compared to controls. These findings provide
further support for a meager cerebral functioning, which ac-
companies a persistently high blood pressure.
Besides recording spatial learning abilities, we also assessed
a more general behavioral profile of the SHR-SP animals
compared to a normotensive age-matched control group in a
novelty-induced behavioral arousal paradigm. The rats were
observed for 60 min in a small open field and their behavioral
activity was recorded. Such a novelty-induced activity test can
help to estimate the exploratory arousal of the animals. The
analysis of the collected data showed that rearing and groom-
ing behavior occurred significantly less frequently in the
SHR-SP group than in the control animals (Fig. 4) which is
regarded indicative for a suppressed behavioral activity. Be-
cause a decaying exploration normally occurs with aging, the
lower arousal level of the SHR-SP rats noted here may refer to
an accelerated aging process that results from chronic hyper-
tension. To know the scale of the actually prevailing hyperten-
sion in the experimental animals, we also recorded the systolic
blood pressure with the tail cuff method under mild ether
anesthesia. The average value for the SHR-SP group was 180
mmHg whereas the blood pressure in normotensive controls
reached an average of 110 mmHg. When we correlated the
blood pressure values with the percentage of intact capillaries,
we found a strong relationship (Fig. 5A). The decreasing in-
cidence of intact microvessels significantly corresponded to the
increasing systolic pressure. In addition, a positive correlation
was established between the rearing scores and the percentage
of healthy cerebral capillaries in the frontal cortex indicating a
higher behavioral activity coinciding with a higher incidence
of intact cerebral capillaries (Fig. 5B). These findings show
that the decaying condition of cerebral microvessels in hyper-
tension can indeed compromise the optimal operation of neu-
ronal networks and the consequent behavioral characteristics.
The above presented 2VO experiments and the SHR-SP
studies of chronic hypertension both presented an example for
the coincidence of cerebral capillary malformations and mem-
ory deficit. We hypothesize that these two degenerative prop-
erties stand in an interactive correspondence. The structural
aberrations of the capillaries penetrating the neural tissue prob-
ably hamper nutrient trafficking to the neuronal cells, thus
compromising an adequate energy production required for
optimal neuronal operation. This suggestion finds support in
the recognition that cytochrome oxidase activity—the terminal
enzyme of the mitochondrial electron transport chain—in the
hippocampus and posterior parietal cortex of 2VO rats is re-
markably decreased [9]. A lower cytochrome oxidase activity
can imply a consequent impairment in ATP synthesis, which
may finally become manifest in cognitive deficits.
5. Conclusion
The present overview has been attempting to elucidate
the nature and consequences of the causal role of hyperten-
sion in the development of cognitive impairment in AD. We
presented relevant animal models, such as the spontane-
Fig. 5. A: The relationship between the percentage of intact capillaries in
the frontal cortex and the systolic blood pressure values in SHR-SP (F) and
WKY (o) rats. The dots represent the mean value per group with standard
deviation bars. The regression line is plotted based on the individual values
of each animal. B: The relationship between the percentage of intact
capillaries in the frontal cortex and frequency of rearing behavior in
SHR-SP (F) and WKY (E) rats (B). The dots represent the individual
animals.
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ously hypertensive rat strain (SHR-SP) and permanent oc-
clusion of the common carotid arteries (2VO) to support and
clarify the findings of human studies on hypertension and
AD. Because our experimental work focused on the causal
factors leading to cerebral microvascular lesions and asso-
ciated cognitive decline, we have emphasized the impor-
tance of cerebrocirculatory deficiencies in the pathophysi-
ology of dementia.
Both animal models, namely SHR-SP and 2VO, verified
the observation of a reduced CBF detected in chronic hy-
pertension and AD in humans. Considering such a remark-
ably coinciding similarity shared by the two conditions
(hypertension and AD) and the reported prevalence of hy-
pertension in dementia, a decreased CBF can be regarded as
a consequence of a chronically high blood pressure. The
lowered CBF can, in turn, give rise to a chain of patholog-
ical events in the brain. As shown by 2VO, a suboptimal
cerebral perfusion can generate typical ultrastructural dam-
age of cerebral capillary walls. Such characteristic morpho-
logical degeneration of microvessels in the brain can be
implicated in a hampered nutrient delivery to the neuropil
and a consequent neuronal metabolic crisis. A convincing
confirmation for this claim can be a decreased cytochrome
oxidase activity observed in 2VO animals. Finally, the in-
adequate availability of energy substrates to the neural tis-
sue can become manifest in a mild but characteristic mem-
ory deficit with its neuropathological correlates (for
example: decreased PKCg activity, increased astrocytic
proliferation or apoptotic cell death). The above described
chain of events followed in experimental animals may cor-
respond with individual observations in AD, such as a
reduced CBF, cerebrocortical capillary lesions, a decreased
metabolic rate for glucose and oxygen in the brain, degen-
erating neuronal integrity and a cognitive impairment. We
suggest that a prevailing hypertensive condition may be
identified as an initial trigger that can lead to such a se-
quence of cerebral events finally contributing to the pro-
gression of AD.
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